BridgeMD
New treatment option for Misophonia
Official title Transcranial Magnetic Stimulation in Misophonia
ClinicalTrials.gov ID: NCT06960083
What this study is testing
- What it's testing
- The purpose of the project is to assess the efficacy of parietal transcranial magnetic stimulation in misophonia. N=60 participants will undergo two transcranial magnetic stimulation sessions: one inhibitory and another excitatory.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- Hypersensitive to presence of a specific sound, which may be accompanied by irritation, anger/outbursts, or fear.
- Must be between the ages of 18 - 55.
- Must be fluent in English since the study's instructions, surveys, and tasks will be in English.
You likely can't join if
- Epilepsy or previous episode of convulsion or seizure.
- Previous episode of fainting spell or syncope.
- Head trauma.
- Hearing problems.
- Cochlear implant.
- Metal in the brain, skull, or anywhere else in the body (e.g., splinters, fragments, clips, etc.).
See the full eligibility criteria
- Hypersensitive to presence of a specific sound, which may be accompanied by irritation, anger/outbursts, or fear.
- Must be between the ages of 18 - 55.
- Must be fluent in English since the study's instructions, surveys, and tasks will be in English.
- Epilepsy or previous episode of convulsion or seizure.
- Previous episode of fainting spell or syncope.
- Head trauma.
- Hearing problems.
- Cochlear implant.
- Metal in the brain, skull, or anywhere else in the body (e.g., splinters, fragments, clips, etc.).
- Implanted neurostimulator (e.g., DBS, epidural/subdural, VNS).
- Presence of cardiac pacemaker or intracardiac lines.
- Presence of medication infusion device.
- Use of pro-convulsant or epileptogenic medications.
- Pregnancy. The risks associated with TMS exposure during gestation have not been studied extensively. We wish to safeguard the health of potential participants and their children.
- Lactation. The risks associated with TMS during lactation and its effects on infant development have not been studied. We wish to safeguard the health of potential participants and their children.
- Presence of Mania, Psychosis, Antisocial Personality Disorder, Borderline Personality Disorder, and Suicidal Ideation.
The study team makes the final eligibility decision.
Where it's taking place
- New York, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New York, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.